SCHEMBL30828602

SCHEMBL30828602

Brc1cccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL180986 1.00
Bromide SCHEMBL14939493 0.97
Bromide SCHEMBL30543193 0.97
Bromide SCHEMBL28136604 0.95
SCHEMBL27694077 0.77 FAAH (0.40)
SCHEMBL131463 0.71
SCHEMBL1456807 0.69 GOT1 (0.46)
SCHEMBL30792004 0.69 GOT1 (0.46)
SCHEMBL29442588 0.69 GOT1 (0.46)
SCHEMBL28175343 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720040-A1 SULFONAMIDE COMPOUNDS BENEFICIAL IN NEUROPROTECTIVE TREATMENT Lario Therapeutics Limited (GB) 2026-04-08 EP disclosed
WO-2024246522-A1 SULFONAMIDE COMPOUNDS BENEFICIAL IN NEUROPROTECTIVE TREATMENT LARIO THERAPEUTICS LIMITED (GB) 2024-12-05 WO disclosed
CN-115557900-B Synthesis method of 3-substituted pyridazine derivative 常州大学 2024-03-15 CN disclosed